O
Oragenics D
D
OGEN
1.33000
USD
0.05
(3.91%)
مغلق
حجم التداول
15
الربح لكل سهم
-11
العائد الربحي
-
P/E
-0
حجم السوق
5,489,140
الأخبار المقالات
العنوان: Oragenics
القطاع: Healthcare
الصناعة: Biotechnology
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. The Company operates in one reportable segment, which includes activities related to advancing the development of its concussion drug, ONP-002.